Affiliations 

  • 1 Department of Pharmaceutics, College of Pharmacy, Jizan University, Jizan, Saudi Arabia
  • 2 Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Asir, Saudi Arabia
  • 3 Faculty of Pharmacy & BioMedical Sciences, MAHSA University, Bandar Saujana Putra, 42610, Jenjarom, Selangor, Malaysia
  • 4 Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt
  • 5 Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, Nizwa, 616, Oman
  • 6 College of Pharmacy and Nursing, University of Nizwa, Birkat Al Mauz, Nizwa, 616, Oman
  • 7 Departments of Medicine and Nanomedicine, Fluorotronics, Inc, and California Innovations Corporation, San Diego, CA, 92037, USA. menaateam@gmail.com
  • 8 Institute of Medicinal and Pharmaceutical Chemistry, Technische Universitaet Braunschweig, Braunschweig, Germany. s.eldeeb@tu-bs.de
Sci Rep, 2024 Mar 16;14(1):6361.
PMID: 38493177 DOI: 10.1038/s41598-024-55953-2

Abstract

Loratadine (LoR) is a highly lipophilic and practically insoluble in water, hence having a low oral bioavailability. As it is formulated as topical gel, it competitively binds with the receptors, thus reducing the side-effects. The objective of this study was to prepare LoR loaded nanosponge (LoR-NS) in gel for topical delivery. Nine different formulations of emulsion were prepared by solvent evaporation method with polyvinyl alcohol (PVA), ethyl cellulose (EC), and dichloromethane (DCM). Based on 32 Full Factorial Design (FFD), optimization was carried out by varying the concentration of LOR:EC ratio and stirring rate. The preparations were subjected for the evaluation of particle size (PS), in vitro release, zeta potential (ZP) and entrapment efficiency (EE). The results revealed that the NS dispersion was nanosized with sustained release profiles and significant PS. The optimised formulation was formulated and incorporated into carbopol 934P hydrogel. The formulation was then examined to surface morphological characterizations using scanning electron microscopy (SEM) which depicted spherical NS. Stability studies, undertaken for 2 months at 40 ± 2 °C/75 ± 5% RH, concluded to the stability of the formulation. The formulation did not cause skin irritation. Therefore, the prepared NS hydrogel proved to be a promising applicant for LoR as a novel drug delivery system (NDDS) for safe, sustained and controlled topical application.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.